Authors : Riya Shrivastav; Shalaka V. Koshti; Aprajeeta Singh; Dr. Rupali Tasgaonkar

Volume/Issue : Volume 9 - 2024, Issue 10 - October

Google Scholar : https://tinyurl.com/bdfbr3au

Scribd : https://tinyurl.com/5d5xdstu

DOI : https://doi.org/10.38124/ijisrt/IJISRT24OCT1724

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Diabetes mellitus, a chronic condition characterized by insufficient insulin production or utilization, has a rich historical context and has evolved significantly since its early identification in ancient civilizations. This article explores the multifaceted nature of diabetes, including its types—Type 1 diabetes (T1D), Type 2 diabetes (T2D), and Latent Autoimmune Diabetes in Adults (LADA)—alongside the pathogenic mechanisms that contribute to its development. The prevalence of diabetes has escalated globally, posing a substantial healthcare burden and leading to serious complications, including cardiovascular diseases and kidney failure. Management strategies have advanced, highlighting the importance of lifestyle modifications, continuous glucose monitoring, and emerging treatments such as artificial pancreas systems, smart insulin, and gene therapy. Furthermore, the potential of stem cell therapy and nanotechnology in the management of diabetes is discussed, indicating a shift towards innovative therapeutic approaches. This comprehensive overview underscores the necessity of tailored treatment strategies and the ongoing research efforts aimed at improving the quality of life for individuals affected by diabetes while addressing the global diabetes epidemic.

Keywords : Diabetes Mellitus, Lifestyle Modifications, Continuous Glucose Monitoring, Gene Therapy, Smart Insulin.

References :

1. Sapra A, Bhandari P. Diabetes. [Updated 2023 Jun 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551501/
2. https://www.who.int/news-room/fact-sheets/detail/diabetes
3. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019. Results. Institute for Health Metrics and Evaluation. 2020 https://vizhub.healthdata.org/gbd-results/
4. American Diabetes Association; Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1 January 2014; 37 (Supplement_1): S81–S90. https://doi.org/10.2337/dc14-S081
5. Boscari, F., Avogaro, A. Current treatment options and challenges in patients with Type 1 diabetes: Pharmacological, technical advances and future perspectives. Rev Endocr Metab Disord 22, 217–240 (2021). https://doi.org/10.1007/s11154-021-09635-35/ https://link.springer.com/article/10.1007/s11154-021-09635-3#Sec1
6. Reed J, Bain S, Kanamarlapudi V. A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives. Diabetes Metab Syndr Obes. 2021;14:3567-3602 https://doi.org/10.2147/DMSO.S3198957.https://www.diabetes.co.uk/diabetes_care/blood-sugar-level-ranges.html#google_vignette
7. Buzzetti R, Tuomi T, Mauricio D, et al. Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel. Diabetes. 2020;69(10):2037-2047. doi:10.2337/dbi20-0017 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809717/
8. Hals I. K. (2019). Treatment of Latent Autoimmune Diabetes in Adults: What is Best?. Current diabetes reviews, 15(3), 188–193. https://doi.org/10.2174/1573399814666180716144429
9. Buzzetti R, Tuomi T, Mauricio D, et al. Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel. Diabetes. 2020;69(10):2037-2047. doi:10.2337/dbi20-0017 https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7809717/bin/dbi200017f1.jpg
10. Vajje J, Khan S, Kaur A, et al. Comparison of the Efficacy of Metformin and Lifestyle Modification for the Primary Prevention of Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. Cureus. 2023;15(10):e47105. Published 2023 Oct 16. doi:10.7759/cureus.47105 www.ncbi.nlm.nih.gov/pmc/articles/PMC10646693/
11. Patel R, Sina RE, Keyes D. Lifestyle Modification for Diabetes and Heart Disease Prevention. [Updated 2024 Feb 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK585052/
12. Physical Activity and Diabetes Sigal, Ronald J. et al.Canadian Journal of Diabetes, Volume 42, S54 - S63 www.canadianjournalofdiabetes.com/article/S1499-2671(17)30818-3/fulltext
13. Reddy N, Verma N, Dungan K. Monitoring Technologies- Continuous Glucose Monitoring, Mobile Technology, Biomarkers of Glycemic Control. [Updated 2023 Jul 8]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279046/
14. Munachiso Nwokolo, Roman Hovorka, The Artificial Pancreas and Type 1 Diabetes, The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 7, July 2023, Pages 1614–1623, https://doi.org/10.1210/clinem/dgad068
15. Lehel, Dénes-Fazakas., Győző, Dénes, Fazakas., György, Eigner., Levente, Kovács., László, Szilágyi. (2024). 1. Review of Reinforcement Learning-Based Control Algorithms in Artificial Pancreas Systems for Diabetes Mellitus Management. doi: 10.1109/saci60582.2024.10619866 https://ieeexplore.ieee.org/document/10619866
16. Weiwen, Fan., Chao, Deng., Rui, Xu., Zhenqi, Liu., Zhou, Zhang., Xia, Li. (2024). 2. 1900-LB: Efficacy and Safety of Artificial Pancreas in Patients with Type 1 Diabetes—A Systematic Review and Meta-analysis. Diabetes, doi: 10.2337/db24-1900-lb https://typeset.io/papers/1900-lb-efficacy-and-safety-of-artificial-pancreas-in-53p5edluij
17. Munachiso Nwokolo, Roman Hovorka, The Artificial Pancreas and Type 1 Diabetes, The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 7, July 2023, Pages 1614–1623, https://doi.org/10.1210/clinem/dgad068
18. Dhankhar, S., Chauhan, S., Mehta, D.K. et al. Novel targets for potential therapeutic use in Diabetes mellitus. Diabetol Metab Syndr 15, 17 (2023). https://doi.org/10.1186/s13098-023-00983-5
19. Wan X-X, Zhang D-Y, Khan MA, Zheng S-Y, Hu X-M, Zhang Q, Yang R-H and Xiong K (2022) Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement. Front. Endocrinol. 13:859638. doi: 10.3389/fendo.2022.859638 www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.859638/full
20. Yangyang Lu, Haojie Yu, Li Wang, Di Shen, Xiang Chen, Yudi Huang, Bilal Ul Amin, Recent advances in the smart insulin delivery systems for the treatment of diabetes, European Polymer Journal, Volume 161, 2021, 110829, ISSN 0014-3057,  https://doi.org/10.1016/j.eurpolymj.2021.110829.
21. (https://www.sciencedirect.com/science/article/pii/S0014305721005632)
22. Srinivasan M, Thangaraj SR, Arzoun H. Gene Therapy - Can it Cure Type 1 Diabetes?. Cureus. 2021;13(12):e20516. Published 2021 Dec 19. doi:10.7759/cureus.20516 www.ncbi.nlm.nih.gov/pmc/articles/PMC8723777/
23. Medically reviewed by Kelly Wood, MD — Written by Christine Fallabel on June 22, 2022 www.healthline.com/health/diabetes/gene-therapy-for-type-1-diabetes
24. Dinesh Kumar Chellappan, Nandhini S. Sivam, Kai Xiang Teoh, Wai Pan Leong, Tai Zhen Fui, Kien Chooi, Nico Khoo, Fam Jia Yi, Jestin Chellian, Lim Lay Cheng, Rajiv Dahiya, Gaurav Gupta, Gautam Singhvi, Srinivas Nammi, Philip Michael Hansbro, Kamal Dua, Gene therapy and type 1 diabetes mellitus, Biomedicine & Pharmacotherapy, Volume 108, 2018, Pages 1188-1200, ISSN 0753-3322, https://doi.org/10.1016/j.biopha.2018.09.138. (https://www.sciencedirect.com/science/article/pii/S0753332218345001)
25. DiSanto RM, Subramanian V, Gu Z. Recent advances in nanotechnology for diabetes treatment. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015;7(4):548-564. doi:10.1002/wnan.1329 www.ncbi.nlm.nih.gov/pmc/articles/PMC4478103/
26. Yannis V. Simos, Konstantinos Spyrou, Michaela Patila, Niki Karouta, Haralambos Stamatis, Dimitrios Gournis, Evangelia Dounousi, Dimitrios Peschos, Trends of nanotechnology in type 2 diabetes mellitus treatment, Asian Journal of Pharmaceutical Sciences, Volume 16, Issue 1, 2021, Pages 62-76, ISSN 1818-0876, https://doi.org/10.1016/j.ajps.2020.05.001. (https://www.sciencedirect.com/science/article/pii/S1818087619310098)
27. Andreadi A, Lodeserto P, Todaro F, Meloni M, Romano M, Minasi A, Bellia A, Lauro D. Nanomedicine in the Treatment of Diabetes. International Journal of Molecular Sciences. 2024; 25(13):7028. https://doi.org/10.3390/ijms25137028